1
|
Zheng Q, Wang YC, Liu QX, Dong XJ, Xie ZX,
Liu XH, Gao W, Bai XJ and Li ZF: FK866 attenuates sepsis-induced
acute lung injury through c-jun-N-terminal kinase (JNK)-dependent
autophagy. Life Sci. 250:1175512020. View Article : Google Scholar : PubMed/NCBI
|
2
|
Tang D, Wang H, Billiar TR, Kroemer G and
Kang R: Emerging mechanisms of immunocoagulation in sepsis and
septic shock. Trends Immunol. 42:508–522. 2021. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhao B, Lu R, Chen J, Xie M, Zhao X and
Kong L: S100A9 blockade prevents lipopolysaccharide-induced lung
injury via suppressing the NLRP3 pathway. Respir Res. 22:452021.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Wu C, Li H, Zhang P, Tian C, Luo J, Zhang
W, Bhandari S, Jin S and Hao Y: Lymphatic flow: A potential target
in sepsis-associated acute lung injury. J Inflamm Res. 13:961–968.
2020. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhang Y, Yu W, Han D, Meng J, Wang H and
Cao G: L-lysine ameliorates sepsis-induced acute lung injury in a
lipopolysaccharide-induced mouse model. Biomed Pharmacother.
118:1093072019. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhou M, Fang H, Du M, Li C, Tang R, Liu H,
Gao Z, Ji Z, Ke B and Chen XL: The modulation of regulatory T cells
via HMGB1/PTEN/β-catenin axis in LPS induced acute lung injury.
Front Immunol. 10:16122019. View Article : Google Scholar
|
7
|
Weiss ARR and Dahlke MH: Immunomodulation
by mesenchymal stem cells (MSCs): Mechanisms of action of living,
apoptotic, and dead MSCs. Front Immunol. 10:11912019. View Article : Google Scholar : PubMed/NCBI
|
8
|
Loke XY, Imran SAM, Tye GJ, Wan Kamarul
Zaman WS and Nordin F: Immunomodulation and regenerative capacity
of MSCs for long-COVID. Int J Mol Sci. 22:124212021. View Article : Google Scholar : PubMed/NCBI
|
9
|
Fu Y, Ni J and Chen J, Ma G, Zhao M, Zhu
S, Shi T, Zhu J, Huang Z, Zhang J and Chen J: Dual-functionalized
MSCs that express CX3CR1 and IL-25 exhibit enhanced therapeutic
effects on inflammatory bowel disease. Mol Ther. 28:1214–1228.
2020. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wu W, Xiao ZX, Zeng D, Huang F, Wang J,
Liu Y, Bellanti JA, Olsen N and Zheng SG: B7-H1 promotes the
functional effect of human gingiva-derived mesenchymal stem cells
on collagen-induced arthritis murine model. Mol Ther. 28:2417–2429.
2020. View Article : Google Scholar : PubMed/NCBI
|
11
|
Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y,
Yang T, Shi L, Fu J, Jiang T, et al: Human umbilical cord-derived
mesenchymal stem cell therapy in patients with COVID-19: A phase 1
clinical trial. Signal Transduct Target Ther. 5:1722020. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhu R, Yan T, Feng Y, Liu Y, Cao H, Peng
G, Yang Y, Xu Z, Liu J, Hou W, et al: Mesenchymal stem cell
treatment improves outcome of COVID-19 patients via multiple
immunomodulatory mechanisms. Cell Res. 31:1244–1262. 2021.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu S, Liu F, Zhou Y, Jin B, Sun Q and Guo
S: Immunosuppressive property of MSCs mediated by cell surface
receptors. Front Immunol. 11:10762020. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hu C, Wu Z and Li L: Mesenchymal stromal
cells promote liver regeneration through regulation of immune
cells. Int J Biol Sci. 16:893–903. 2020. View Article : Google Scholar : PubMed/NCBI
|
15
|
L PK, Kandoi S, Misra R, S V, K R and
Verma RS: The mesenchymal stem cell secretome: A new paradigm
towards cell-free therapeutic mode in regenerative medicine.
Cytokine Growth Factor Rev. 46:1–9. 2019. View Article : Google Scholar : PubMed/NCBI
|
16
|
Phan J, Kumar P, Hao D, Gao K, Farmer D
and Wang A: Engineering mesenchymal stem cells to improve their
exosome efficacy and yield for cell-free therapy. J Extracell
Vesicles. 7:15222362018. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wechsler ME, Rao VV, Borelli AN and Anseth
KS: Engineering the MSC secretome: A hydrogel focused approach. Adv
Healthc Mater. 10:e20019482021. View Article : Google Scholar : PubMed/NCBI
|
18
|
Chang C, Yan J, Yao Z, Zhang C, Li X and
Mao HQ: Effects of mesenchymal stem cell-derived paracrine signals
and their delivery strategies. Adv Healthc Mater. 10:e20016892021.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Song N, Scholtemeijer M and Shah K:
Mesenchymal stem cell immunomodulation: Mechanisms and therapeutic
potential. Trends Pharmacol Sci. 41:653–664. 2020. View Article : Google Scholar : PubMed/NCBI
|
20
|
Jakob M, Hemeda H, Janeschik S, Bootz F,
Rotter N, Lang S and Brandau S: Human nasal mucosa contains
tissue-resident immunologically responsive mesenchymal stromal
cells. Stem Cells Dev. 19:635–644. 2010. View Article : Google Scholar
|
21
|
Hong CG, Chen ML, Duan R, Wang X, Pang ZL,
Ge LT, Lu M, Xie H and Liu ZZ: Transplantation of nasal olfactory
mucosa mesenchymal stem cells benefits Alzheimer's disease. Mol
Neurobiol. 59:7323–7336. 2022. View Article : Google Scholar : PubMed/NCBI
|
22
|
Afonina IS, Zhong Z, Karin M and Beyaert
R: Limiting inflammation-the negative regulation of NF-κB and the
NLRP3 inflammasome. Nat Immunol. 18:861–869. 2017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Halova I, Rönnberg E, Draberova L,
Vliagoftis H, Nilsson GP and Draber P: Changing the
threshold-Signals and mechanisms of mast cell priming. Immunol Rev.
282:73–86. 2018. View Article : Google Scholar : PubMed/NCBI
|
24
|
Luo B, Huang F, Liu Y, Liang Y, Wei Z, Ke
H, Zeng Z, Huang W and He Y: NLRP3 inflammasome as a molecular
marker in diabetic cardiomyopathy. Front Physiol. 8:5192017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Huang Y, Xu W and Zhou R: NLRP3
inflammasome activation and cell death. Cell Mol Immunol.
18:2114–2127. 2021. View Article : Google Scholar : PubMed/NCBI
|
26
|
He X, Yang W, Zeng Z, Wei Y, Gao J, Zhang
B, Li L, Liu L, Wan Y, Zeng Q, et al: NLRP3-dependent pyroptosis is
required for HIV-1 gp120-induced neuropathology. Cell Mol Immunol.
17:283–299. 2020. View Article : Google Scholar :
|
27
|
Hickey AJ: Emerging trends in inhaled drug
delivery. Adv Drug Deliv Rev. 157:63–70. 2020. View Article : Google Scholar : PubMed/NCBI
|
28
|
Sudduth ER, Trautmann-Rodriguez M, Gill N,
Bomb K and Fromen CA: Aerosol pulmonary immune engineering. Adv
Drug Deliv Rev. 199:1148312023. View Article : Google Scholar : PubMed/NCBI
|
29
|
Takaenoki Y, Masui K, Oda Y and Kazama T:
The pharmacokinetics of atomized lidocaine administered via the
Trachea: A randomized trial. Anesth Analg. 123:74–81. 2016.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Shi W, Wang Z, Bian L, Wu Y, HuiYa M, Zhou
Y, Zhang Z, Wang Q, Zhao P and Lu X: Periodic heat stress licenses
EMSC differentiation into osteoblasts via YAP signaling pathway
activation. Stem Cells Int. 2022:37154712022. View Article : Google Scholar : PubMed/NCBI
|
31
|
Peng W, Chang M, Wu Y, Zhu W, Tong L,
Zhang G, Wang Q, Liu J, Zhu X, Cheng T, et al: Lyophilized powder
of mesenchymal stem cell supernatant attenuates acute lung injury
through the IL-6-p-STAT3-p63-JAG2 pathway. Stem Cell Res Ther.
12:2162021. View Article : Google Scholar : PubMed/NCBI
|
32
|
Lainé A, Labiad O, Hernandez-Vargas H,
This S, Sanlaville A, Léon S, Dalle S, Sheppard D, Travis MA,
Paidassi H and Marie JC: Regulatory T cells promote cancer
immune-escape through integrin αvβ8-mediated TGF-β activation. Nat
Commun. 12:62282021. View Article : Google Scholar
|
33
|
Ouyang W, Rutz S, Crellin NK, Valdez PA
and Hymowitz SG: Regulation and functions of the IL-10 family of
cytokines in inflammation and disease. Annu Rev Immunol. 29:71–109.
2011. View Article : Google Scholar
|
34
|
Garg C, Khan H, Kaur A, Singh TG, Sharma
VK and Singh SK: Therapeutic implications of sonic hedgehog pathway
in metabolic disorders: Novel target for effective treatment.
Pharmacol Res. 179:1061942022. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhao X, Zhao Y, Sun X, Xing Y, Wang X and
Yang Q: Immunomodulation of MSCs and MSC-derived extracellular
vesicles in osteoarthritis. Front Bioeng Biotechnol. 8:5750572020.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Li Y, Huang J, Foley NM, Xu Y, Li YP, Pan
J, Redmond HP, Wang JH and Wang J: B7H3 ameliorates LPS-induced
acute lung injury via attenuation of neutrophil migration and
infiltration. Sci Rep. 6:312842016. View Article : Google Scholar : PubMed/NCBI
|
37
|
Suzuki K, Okada H, Takemura G, Takada C,
Tomita H, Yano H, Muraki I, Zaikokuji R, Kuroda A, Fukuda H, et al:
Recombinant thrombomodulin protects against LPS-induced acute
respiratory distress syndrome via preservation of pulmonary
endothelial glycocalyx. Br J Pharmacol. 177:4021–4033. 2020.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Baumgarten G, Knuefermann P, Wrigge H,
Putensen C, Stapel H, Fink K, Meyer R, Hoeft A and Grohé C: Role of
Toll-like receptor 4 for the pathogenesis of acute lung injury in
Gram-negative sepsis. Eur J Anaesthesiol. 23:1041–1048. 2006.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Shaaban AA, El-Kashef DH, Hamed MF and
El-Agamy DS: Protective effect of pristimerin against LPS-induced
acute lung injury in mice. Int Immunopharmacol. 59:31–39. 2018.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Zhang X, Zhang P, An L, Sun N, Peng L,
Tang W, Ma D and Chen J: Miltirone induces cell death in
hepatocellular carcinoma cell through GSDME-dependent pyroptosis.
Acta Pharm Sin B. 10:1397–1413. 2020. View Article : Google Scholar : PubMed/NCBI
|
41
|
Plonka PM, Michalczyk D, Popik M,
Handjiski B, Slominski A and Paus R: Splenic eumelanin differs from
hair eumelanin in C57BL/6 mice. Acta Biochim Pol. 52:433–441. 2005.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Michalczyk D, Popik M, Salwinski A and
Plonka PM: Extradermal melanin transfer? Lack of macroscopic spleen
melanization in old C57BL/6 mice with de-synchronized hair cycle.
Acta Biochim Pol. 56:343–353. 2009. View Article : Google Scholar : PubMed/NCBI
|
43
|
Davies MJ: Myeloperoxidase: Mechanisms,
reactions and inhibition as a therapeutic strategy in inflammatory
diseases. Pharmacol Ther. 218:1076852021. View Article : Google Scholar
|
44
|
van Loo G and Bertrand MJM: Death by TNF:
A road to inflammation. Nat Rev Immunol. 23:289–303. 2023.
View Article : Google Scholar
|
45
|
Płóciennikowska A, Hromada-Judycka A,
Borzęcka K and Kwiatkowska K: Co-operation of TLR4 and raft
proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life
Sci. 72:557–581. 2015. View Article : Google Scholar
|
46
|
Fajgenbaum DC and June CH: Cytokine storm.
N Engl J Med. 383:2255–2273. 2020. View Article : Google Scholar : PubMed/NCBI
|
47
|
Chousterman BG, Swirski FK and Weber GF:
Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol.
39:517–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
48
|
Kumar V: Toll-like receptors in
sepsis-associated cytokine storm and their endogenous negative
regulators as future immunomodulatory targets. Int Immunopharmacol.
89:1070872020. View Article : Google Scholar : PubMed/NCBI
|
49
|
Kim JS, Lee JY, Yang JW, Lee KH,
Effenberger M, Szpirt W, Kronbichler A and Shin JI:
Immunopathogenesis and treatment of cytokine storm in COVID-19.
Theranostics. 11:316–329. 2021. View Article : Google Scholar : PubMed/NCBI
|
50
|
Matthay MA, Zemans RL, Zimmerman GA, Arabi
YM, Beitler JR, Mercat A, Herridge M, Randolph AG and Calfee CS:
Acute respiratory distress syndrome. Nat Rev Dis Primers. 5:182019.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Huang M, Cai S and Su J: The pathogenesis
of sepsis and potential therapeutic targets. Int J Mol Sci.
20:53762019. View Article : Google Scholar : PubMed/NCBI
|
52
|
Asgari Taei A, Khodabakhsh P, Nasoohi S,
Farahmandfar M and Dargahi L: Paracrine effects of mesenchymal stem
cells in ischemic stroke: Opportunities and challenges. Mol
Neurobiol. 59:6281–6306. 2022. View Article : Google Scholar : PubMed/NCBI
|
53
|
Tran C and Damaser MS: Stem cells as drug
delivery methods: Application of stem cell secretome for
regeneration. Adv Drug Deliv Rev. 82-83:1–11. 2015. View Article : Google Scholar
|
54
|
Fröhlich E and Salar-Behzadi S: Oral
inhalation for delivery of proteins and peptides to the lungs. Eur
J Pharm Biopharm. 163:198–211. 2021. View Article : Google Scholar : PubMed/NCBI
|
55
|
Gelfand CA, Sakurai R, Wang Y, Liu Y,
Segal R and Rehan VK: Inhaled vitamin A is more effective than
intramuscular dosing in mitigating hyperoxia-induced lung injury in
a neonatal rat model of bronchopulmonary dysplasia. Am J Physiol
Lung Cell Mol Physiol. 319:L576–L584. 2020. View Article : Google Scholar : PubMed/NCBI
|
56
|
Lee WH, Loo CY, Traini D and Young PM:
Development and evaluation of paclitaxel and curcumin dry powder
for inhalation lung cancer treatment. Pharmaceutics. 13:92020.
View Article : Google Scholar : PubMed/NCBI
|
57
|
Sakurai R, Lee C, Shen H, Waring AJ,
Walther FJ and Rehan VK: A combination of the aerosolized PPAR-γ
agonist pioglitazone and a synthetic surfactant protein B peptide
mimic prevents hyperoxia-induced neonatal lung injury in rats.
Neonatology. 113:296–304. 2018. View Article : Google Scholar
|
58
|
Interdonato L, D'amico R, Cordaro M,
Siracusa R, Fusco R, Peritore AF, Gugliandolo E, Crupi R, Coaccioli
S, Genovese T, et al: Aerosol-administered adelmidrol attenuates
lung inflammation in a murine model of acute lung injury.
Biomolecules. 12:13082022. View Article : Google Scholar : PubMed/NCBI
|
59
|
Ouyang W and O'Garra A: IL-10 family
cytokines IL-10 and IL-22: From basic science to clinical
translation. Immunity. 50:871–891. 2019. View Article : Google Scholar : PubMed/NCBI
|
60
|
Saraiva M, Vieira P and O'Garra A: Biology
and therapeutic potential of interleukin-10. J Exp Med.
217:e201904182020. View Article : Google Scholar :
|
61
|
Engelhardt KR and Grimbacher B: IL-10 in
humans: Lessons from the gut, IL-10/IL-10 receptor deficiencies,
and IL-10 polymorphisms. Curr Top Microbiol Immunol. 380:1–18.
2014.PubMed/NCBI
|
62
|
Mollazadeh H, Cicero AFG, Blesso CN, Pirro
M, Majeed M and Sahebkar A: Immune modulation by curcumin: The role
of interleukin-10. Crit Rev Food Sci Nutr. 59:89–101. 2019.
View Article : Google Scholar
|
63
|
Chen Z, Bozec A, Ramming A and Schett G:
Anti-inflammatory and immune-regulatory cytokines in rheumatoid
arthritis. Nat Rev Rheumatol. 15:9–17. 2019. View Article : Google Scholar
|
64
|
Asadullah K, Döcke WD, Sabat RV, Volk HD
and Sterry W: The treatment of psoriasis with IL-10: Rationale and
review of the first clinical trials. Expert Opin Investig Drugs.
9:95–102. 2000. View Article : Google Scholar : PubMed/NCBI
|
65
|
Tumes DJ, Papadopoulos M, Endo Y, Onodera
A, Hirahara K and Nakayama T: Epigenetic regulation of T-helper
cell differentiation, memory, and plasticity in allergic asthma.
Immunol Rev. 278:8–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
66
|
Koelink PJ, Bloemendaal FM, Li B, Westera
L, Vogels EWM, van Roest M, Gloudemans AK, van't Wout AB, Korf H,
Vermeire S, et al: Anti-TNF therapy in IBD exerts its therapeutic
effect through macrophage IL-10 signalling. Gut. 69:1053–1063.
2020. View Article : Google Scholar
|
67
|
Wang Z, Zhang X, Qi L, Feng W, Gu Y and
Ding Y: Olfactory mucosa tissue-derived mesenchymal stem cells
lysate ameliorates LPS-induced acute liver injury in mice. BMC Pulm
Med. 22:4142022. View Article : Google Scholar : PubMed/NCBI
|
68
|
Tan HL and Rosenthal M: IL-17 in lung
disease: Friend or foe? Thorax. 68:788–790. 2013. View Article : Google Scholar : PubMed/NCBI
|
69
|
Ge Y, Huang M and Yao YM: Biology of
interleukin-17 and its pathophysiological significance in sepsis.
Front Immunol. 11:15582020. View Article : Google Scholar : PubMed/NCBI
|
70
|
Peng T, Frank DB, Kadzik RS, Morley MP,
Rathi KS, Wang T, Zhou S, Cheng L, Lu MM and Morrisey EE: Hedgehog
actively maintains adult lung quiescence and regulates repair and
regeneration. Nature. 526:578–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
71
|
Pepicelli CV, Lewis PM and McMahon AP:
Sonic hedgehog regulates branching morphogenesis in the mammalian
lung. Curr Biol. 8:1083–1086. 1998. View Article : Google Scholar : PubMed/NCBI
|
72
|
Hyun J, Wang S, Kim J, Kim GJ and Jung Y:
MicroRNA125b-mediated Hedgehog signaling influences liver
regeneration by chorionic plate-derived mesenchymal stem cells. Sci
Rep. 5:141352015. View Article : Google Scholar : PubMed/NCBI
|
73
|
Qi J, Zhou Y, Jiao Z, Wang X, Zhao Y and
Li Y, Chen H, Yang L, Zhu H and Li Y: Exosomes derived from human
bone marrow mesenchymal stem cells promote tumor growth through
hedgehog signaling pathway. Cell Physiol Biochem. 42:2242–2254.
2017. View Article : Google Scholar : PubMed/NCBI
|
74
|
Zhao N, Di B and Xu LL: The NLRP3
inflammasome and COVID-19: Activation, pathogenesis and therapeutic
strategies. Cytokine Growth Factor Rev. 61:2–15. 2021. View Article : Google Scholar : PubMed/NCBI
|
75
|
Coll RC, Schroder K and Pelegrín P: NLRP3
and pyroptosis blockers for treating inflammatory diseases. Trends
Pharmacol Sci. 43:653–668. 2022. View Article : Google Scholar : PubMed/NCBI
|
76
|
Latour A, Gu Y, Kassis N, Daubigney F,
Colin C, Gausserès B, Middendorp S, Paul JL, Hindié V, Rain JC, et
al: LPS-induced inflammation abolishes the effect of DYRK1A on IkB
stability in the brain of mice. Mol Neurobiol. 56:963–975. 2019.
View Article : Google Scholar
|
77
|
Wei Y, Yang L, Pandeya A, Cui J, Zhang Y
and Li Z: Pyroptosis-induced inflammation and tissue damage. J Mol
Biol. 434:1673012021. View Article : Google Scholar : PubMed/NCBI
|
78
|
de Vasconcelos NM and Lamkanfi M: Recent
insights on inflammasomes, gasdermin pores, and pyroptosis. Cold
Spring Harb Perspect Biol. 12:a0363922020. View Article : Google Scholar
|